Compare TGTX & CBSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TGTX | CBSH |
|---|---|---|
| Founded | 1993 | 1865 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 7.6B |
| IPO Year | 2008 | 2008 |
| Metric | TGTX | CBSH |
|---|---|---|
| Price | $55.16 | $58.63 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 8 |
| Target Price | $49.80 | ★ $58.28 |
| AVG Volume (30 Days) | ★ 2.8M | 1.3M |
| Earning Date | 05-04-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 2.15% |
| EPS Growth | ★ 1746.67 | 4.39 |
| EPS | 0.12 | ★ 0.96 |
| Revenue | ★ $2,785,000.00 | N/A |
| Revenue This Year | $49.08 | $17.43 |
| Revenue Next Year | $26.69 | $3.43 |
| P/E Ratio | $457.67 | ★ $60.15 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $25.37 | $46.99 |
| 52 Week High | $57.38 | $66.31 |
| Indicator | TGTX | CBSH |
|---|---|---|
| Relative Strength Index (RSI) | 77.96 | 75.48 |
| Support Level | $28.57 | $51.60 |
| Resistance Level | $57.38 | $60.21 |
| Average True Range (ATR) | 2.39 | 0.94 |
| MACD | 0.24 | 0.28 |
| Stochastic Oscillator | 81.53 | 98.52 |
TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.
Commerce Bancshares Inc operates as the bank holding company for Commerce Bank. The bank is engaged in the general banking business, providing a broad range of retail, mortgage banking, corporate, investment, trust, and asset management products and services to individuals, businesses, and municipalities. The company has three reportable segments. The Commercial segment provides lending, leasing, deposit, payment, and cash management services to business and government customers. The Retail Banking segment offers consumer deposits, consumer lending, mortgage banking, and debit and credit card services through its branch network. The Wealth segment provides trust, estate planning, brokerage, and investment management services to individual and institutional clients.